Teleflex Medical Expands Respiratory Offering With Nasal-Aire II Critical Care
 |
|
 |
BANNOCKBURN, Ill., Sep 13, 2005
(BUSINESS WIRE) -- The Teleflex Medical Products, a division of
Teleflex Incorporated (TFX), announced today it has entered an
exclusive U.S. distribution agreement for the Nasal-Aire(R) II
Critical Care patient interface developed by InnoMed Technologies,
Inc.
"We are very pleased with our new relationship with Teleflex
Medical," stated Sanjay Chandran, CEO of InnoMed Technologies, "It
is the ideal business partner to bring the patented Nasal-Aire(R)
technology into the critical care marketplace."
The Nasal-Aire(R) II Critical Care patient interface is a single
patient use, disposable device intended for use in the hospital and
other critical care settings for the administration of non-invasive
ventilation (NIV). It features a patented nosepiece unique to the
marketplace that seals on the inside of the nose rather than being
compressed against it. This design makes the bulky headgear required
to achieve a seal with traditional NIV patient interfaces obsolete,
eliminating pressure on the face and bridge of the nose. This
patient-friendly device also allows the user to converse, eat, drink
and wear glasses while receiving therapy, actions that cannot easily
be done with other NIV mask options.
"We are very excited about the prospect of selling the Nasal-Aire(R)
II Critical Care interface product as it complements our existing
lines and our future initiatives in NIV," said Richard Kindberg,
Senior Vice President Teleflex Medical and General Manager of the
Medical Products Division. Kindberg explained further, "We are also
confident that the improved level of patient comfort this product
offers will lead to increased therapy compliance and better patient
outcomes - all at an affordable price."
About Teleflex Medical
Teleflex Medical, a division of Teleflex Incorporated, is a leading
global supplier of disposable medical products, surgical instruments
and medical devices. The division supports health providers along
the continuum of care in three main areas:
-- Devices for urology, anesthesiology, gastroenterology and
respiratory care
-- Surgical instruments and related services
-- Original Equipment Manufacturers
Teleflex Medical markets health care supplies under the Hudson RCI
and Rusch brand names and surgical instruments and medical devices
under the Beere, CVevolutions, Deknatel, KMedic, Pilling and Week
brands. In 2004, Teleflex Medical had revenues of $745 million.
About InnoMed Technologies
InnoMed Technologies, Inc. is a global corporation involved in R&D,
manufacturing and marketing of medical devices to treat sleep apnea
and other respiratory disorders. With headquarters in Coconut Creek,
FL, the company is responsible for the design and introduction to
the market of the patented Nasal-Aire(R) technology and many other
innovative medical products. Additional information on InnoMed
Technologies can be obtained at http://www.InnoMedInc.com.
About Teleflex Incorporated
Teleflex Incorporated (TFX) is a diversified company with annual
revenues of $2.4 billion. Teleflex designs, manufactures and
distributes quality engineered products and services for the
aerospace, automotive, marine, industrial and medical markets
worldwide. Headquartered in Limerick, PA, with operations in 26
countries, Teleflex employs more than 20,000 people worldwide who
focus on providing innovative solutions for customers. Additional
information about Teleflex, including a recent archived conference
call with analysts and investors, can be obtained from the Company's
website on the Internet at
http://www.Teleflex.com.
SOURCE: Teleflex Medical Products
Teleflex Medical Products, Bannockburn
Marc Burk, 1-800-848-3766 ext.1290
mburk@teleflexmedical.com
|
|
